Michael Lynes recently received a $500K Connecticut Biosciences Innovation Fund (CBIF) Award

This award, from Connecticut Innovations, is for work entitled  “A Therapeutic Monoclonal Antibody for the Treatment of Inflammatory Bowel Disease”.